+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronary Drug-Coated Balloon Catheter Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • August 2026
  • Region: Global
  • Grand View Research
  • ID: 6285270
REQUEST CUSTOMIZATION
Description Jump to:
The global coronary drug-coated balloon catheter market size was valued at USD 342.4 million in 2025 and is projected to grow from USD 374.9 million in 2026 to USD 727.2 million by 2033, at a CAGR of 9.9% from 2026 to 2033. North America dominated the market, accounting for a share of 44.1% in 2025. Increasing Percutaneous Coronary Intervention (PCI) volumes globally are driving the demand for coronary drug-coated balloon catheters, particularly for treating in-stent restenosis and complex coronary lesions.

In addition, comprehensive reimbursement coverage for coronary interventions in countries such as the U.S., Germany, and Japan is improving patient access and accelerating the adoption of drug-coated balloon technologies.

Market Dynamic

The rising prevalence of coronary artery disease (CAD), increasing volumes of PCI procedures, and growing adoption of minimally invasive coronary revascularization techniques are driving the growth of the coronary drug-coated balloon catheter market. Increasing incidences of in-stent restenosis (ISR), small vessel disease, and complex coronary lesions are accelerating the demand for an effective alternative to repeat stenting. Continuous advancements in drug-coating technologies, particularly the development of next-generation sirolimus-coated balloons, along with expanding clinical evidence and favorable regulatory approvals, are further supporting market adoption.
However, stringent regulatory approval requirements, extensive clinical trial obligations, and the high cost of advanced interventional procedures continue to restrain market growth. Expanding commercialization of innovative technologies, increasing physician preference for "leave nothing behind" treatment strategies, and growing adoption across emerging healthcare markets are expected to create significant growth opportunities during the forecast period.

Global Coronary Drug-Coated Balloon Catheter Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels, and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global coronary drug-coated balloon catheter market report on the basis of indication, drug type, end use, and region:

Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • In-Stent Restenosis (ISR)
  • De-novo coronary lesions
  • Complex / Adjunct Coronary Lesions

Drug Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Paclitaxel
  • Sirolimus
  • Others

End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals
  • Specialty Cardiac/Vascular Centers
  • Ambulatory Surgical Centers (ASCs)

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
  • Latin America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Indication
1.1.2. Drug Type
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. The internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Indication outlook
2.2.2. Drug type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Coronary Drug-Coated Balloon Catheters Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenge analysis
3.3. Coronary Drug-Coated Balloon Catheters Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
3.4. Country-Level Market Driver Mapping (Coronary DCB)
3.4.1. Regulatory Landscape Influencing the Coronary Drug-Coated Balloon Market Dynamics
3.4.2. Clinical Trial Presence in Major Countries
3.4.3. Global Distribution Footprint
3.4.4. Pricing Competitiveness
3.5. Innovation & Product Development Analysis
3.5.1. New Product Launches
3.5.2. Product Pipeline
3.5.3. Emerging Coating Technologies
3.6. Market Entry Attractiveness Assessment
Chapter 4. Coronary Drug-Coated Balloon Catheters Market: Indication Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Indication Market Share, 2025 & 2033
4.3. Segment Dashboard
4.4. Coronary Drug-Coated Balloon Catheters Market by Indication Area Outlook
4.5. In-Stent Restenosis (ISR)
4.5.1. In-stent restenosis (ISR) market estimates and forecast, 2021 to 2033 (USD Million)
4.6. De-novo Coronary Lesions
4.6.1. De-novo coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)
4.7. Complex / Adjunct Coronary Lesions
4.7.1. Complex / adjunct coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 5. Coronary Drug-Coated Balloon Catheters Market: Technology Integration Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Drug Type Market Share, 2025 & 2033
5.3. Segment Dashboard
5.4. Coronary Drug-Coated Balloon Catheters Market by Drug Type Outlook
5.5. Paclitaxel
5.5.1. Paclitaxel market estimates and forecast, 2021 to 2033 (USD Million)
5.6. Sirolimus
5.6.1. Sirolimus market estimates and forecast, 2021 to 2033 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 6. Coronary Drug-Coated Balloon Catheters Market: End Use Estimates & Trend Analysis
6.1. Definition and Scope
6.2. End Use Market Share, 2025 & 2033
6.3. Segment Dashboard
6.4. Coronary Drug-Coated Balloon Catheters Market by End Use Outlook
6.5. E- Hospitals
6.5.1. Hospitals market estimates and forecast, 2021 to 2033 (USD Million)
6.6. Specialty Cardiac/Vascular Centers
6.6.1. Specialty cardiac/vascular centers market estimates and forecast, 2021 to 2033 (USD Million)
6.7. Ambulatory Surgical Centers (ASCs)
6.7.1. Ambulatory surgical centers (ASCs) market estimates and forecast, 2021 to 2033 (USD Million)
Chapter 7. Coronary Drug-Coated Balloon Catheters Market: Regional Estimates & Trend Analysis, Indication, Drug Type, End Use
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.1.5. U.S. market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2.5. Canada market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3.5. Mexico market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.1.5. UK market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2.5. Germany market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3.5. France market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4.5. Italy market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5.5. Spain market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6.5. Norway market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7.5. Sweden market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8.5. Denmark market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.1.5. Japan market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2.5. China market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3.5. India market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4.5. Australia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5.5. South Korea market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6.5. Thailand market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.7. Indonesia
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Indonesia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7.5. Indonesia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.8. Malaysia
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Competitive scenario
7.6.8.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.8.5. Malaysia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.9. Vietnam
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework
7.6.9.3. Competitive scenario
7.6.9.4. Vietnam market estimates and forecasts 2021 to 2033 (USD Million)
7.6.9.5. Vietnam market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.1.5. Brazil market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2.5. Argentina market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.3. Colombia
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. Colombia market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3.5. Colombia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.4. Chile
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive scenario
7.7.4.4. Chile market estimates and forecasts 2021 to 2033 (USD Million)
7.7.4.5. Chile market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.1.5. South Africa market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2.5. Saudi Arabia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3.5. UAE market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4.5. Kuwait market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, Key Market Participants
8.2. Company/Competition Categorization
8.3. Key Company Market Share Analysis, 2025 (%)
8.4. List of Companies
8.4.1. Boston Scientific
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Lepu Medical
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Medtronic
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. B. Braun SE
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Concept Medical
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Teleflex Incorporated (BIOTRONIK)
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. MicroPort Scientific Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. iVascular S.L.U.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 4 North America coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 5 North America coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 6 North America coronary drug-coated balloon catheter Market, Country, 2021 - 2033 (USD Million)
Table 7 U.S. coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 8 U.S. coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 9 U.S. coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 10 Canada coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 11 Canada coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 12 Canada coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 13 Mexico coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 14 Mexico coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 15 Mexico coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 16 Europe coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 17 Europe coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 18 Europe coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 19 Europe coronary drug-coated balloon catheter Market, Country, 2021 - 2033 (USD Million)
Table 20 UK coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 21 UK coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 22 UK coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 23 Germany coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 24 Germany coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 25 Germany coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 26 France coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 27 France coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 28 France coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 29 Italy coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 30 Italy coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 31 Italy coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 32 Spain coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 33 Spain coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 34 Spain coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 35 Denmark coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 36 Denmark coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 37 Denmark coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 38 Sweden coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 39 Sweden coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 40 Sweden coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 41 Norway coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 42 Norway coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 43 Norway coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 44 Asia Pacific coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 45 Asia Pacific coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 46 Asia Pacific coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 47 Asia Pacific coronary drug-coated balloon catheter Market, Country, 2021 - 2033 (USD Million)
Table 48 China coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 49 China coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 50 China coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 51 Japan coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 52 Japan coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 53 Japan coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 54 India coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 55 India coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 56 India coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 57 Australia coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 58 Australia coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 59 Australia coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 60 South Korea coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 61 South Korea coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 62 South Korea coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 63 Thailand coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 64 Thailand coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 65 Thailand coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 66 Indonesia coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 67 Indonesia coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 68 Indonesia coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 69 Malaysia coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 70 Malaysia coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 71 Malaysia coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 72 Vietnam coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 73 Vietnam coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 74 Vietnam coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 75 Latin America coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 76 Latin America coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 77 Latin America coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 78 Latin America coronary drug-coated balloon catheter Market, Country, 2021 - 2033 (USD Million)
Table 79 Brazil coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 80 Brazil coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 81 Brazil coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 82 Argentina coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 83 Argentina coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 84 Argentina coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 85 Colombia coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 86 Colombia coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 87 Colombia coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 88 Chile coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 89 Chile coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 90 Chile coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 91 MEA coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 92 MEA coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 93 MEA coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 94 MEA coronary drug-coated balloon catheter Market, Country, 2021 - 2033 (USD Million)
Table 95 South Africa coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 96 South Africa coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 97 South Africa coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 98 Saudi Arabia coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 99 Saudi Arabia coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 100 Saudi Arabia coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 101 UAE coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 102 UAE coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 103 UAE coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
Table 104 Kuwait coronary drug-coated balloon catheter market, Indication, 2021 - 2033 (USD Million)
Table 105 Kuwait coronary drug-coated balloon catheter market, Drug type, 2021 - 2033 (USD Million)
Table 106 Kuwait coronary drug-coated balloon catheter market, End use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Coronary drug-coated balloon catheter: Market outlook
Figure 9 Coronary drug-coated balloon catheter: Competitive Insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Coronary drug-coated balloon catheter market driver impact
Figure 15 Coronary drug-coated balloon catheter market restraint impact
Figure 16 Coronary drug-coated balloon catheter market strategic initiative
Figure 17 Coronary drug-coated balloon catheter market: Indication movement
Figure 18 Coronary drug-coated balloon catheter market: Indication outlook
Figure 19 In-stent restenosis (ISR) market estimates and forecasts, 2021 - 2033
Figure 20 De-novo coronary lesions market estimates and forecasts, 2021 - 2033
Figure 21 Complex / adjunct coronary lesions market estimates and forecasts, 2021 - 2033
Figure 22 Coronary drug-coated balloon catheter market: Drug type movement
Figure 23 Coronary drug-coated balloon catheter market: Drug type outlook
Figure 24 Paclitaxel market estimates and forecasts, 2021 - 2033
Figure 25 Sirolimus market estimates and forecasts, 2021 - 203
Figure 26 Others market estimates and forecasts, 2021 - 2033
Figure 27 Coronary drug-coated balloon catheter market: End use movement
Figure 28 Coronary drug-coated balloon catheter market: End use outlook
Figure 29 Hospitals market estimates and forecasts, 2021 - 2033
Figure 30 Specialty cardiac/vascular centers market estimates and forecasts, 2021 - 203
Figure 31 Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 - 2033
Figure 32 Coronary drug-coated balloon catheter market: Regional
Figure 33 Coronary drug-coated balloon catheter market: Regional
Figure 34 North America market estimates and forecasts, 2021 - 2033
Figure 35 US market estimates and forecasts, 2021 - 2033
Figure 36 Canada market estimates and forecasts, 2021 - 2033
Figure 37 Mexico market estimates and forecasts, 2021 - 2033
Figure 38 Europe market estimates and forecasts, 2021 - 2033
Figure 39 UK market estimates and forecasts, 2021 - 2033
Figure 40 Germany market estimates and forecasts, 2021 - 2033
Figure 41 France market estimates and forecasts, 2021 - 2033
Figure 42 Italy market estimates and forecasts, 2021 - 2033
Figure 43 Spain market estimates and forecasts, 2021 - 2033
Figure 44 Sweden market estimates and forecasts, 2021 - 2033
Figure 45 Norway market estimates and forecasts, 2021 - 2033
Figure 46 Denmark market estimates and forecasts, 2021 - 2033
Figure 47 Asia Pacific market estimates and forecasts, 2021 - 2033
Figure 48 Japan market estimates and forecasts, 2021 - 2033
Figure 49 China market estimates and forecasts, 2021 - 2033
Figure 50 India market estimates and forecasts, 2021 - 2033
Figure 51 Australia market estimates and forecasts, 2021 - 2033
Figure 52 Thailand market estimates and forecasts, 2021 - 2033
Figure 53 South Korea market estimates and forecasts, 2021 - 2033
Figure 54 Indonesia market estimates and forecasts, 2021 - 2033
Figure 55 Malaysia market estimates and forecasts, 2021 - 2033
Figure 56 Vietnam market estimates and forecasts, 2021 - 2033
Figure 57 Latin America market estimates and forecasts, 2021 - 2033
Figure 58 Brazil market estimates and forecasts, 2021 - 2033
Figure 59 Argentina market estimates and forecasts, 2021 - 2033
Figure 60 Colombia market estimates and forecasts, 2021 - 2033
Figure 61 Chile market estimates and forecasts, 2021 - 2033
Figure 62 Middle East and Africa market estimates and forecasts, 2021 - 2033
Figure 63 Saudi Arabia market estimates and forecasts, 2021 - 2033
Figure 64 South Africa market estimates and forecasts, 2021 - 2033
Figure 65 UAE market estimates and forecasts, 2021 - 2033
Figure 66 Kuwait market estimates and forecasts, 2021 - 2033

Companies Mentioned

  • Boston Scientific Corporation
  • Medtronic
  • B. Braun SE
  • Concept Medical
  • Teleflex Incorporated (BIOTRONIK)
  • MicroPort Scientific Corporation
  • iVascular S.L.U.
  • Lepu Medical

Related Topics

Related Reports

Drug-Coated Balloon Catheter Market Size, Share & Trends Analysis Report by Type, End Use, Region, and Growth Forecasts, 2026-2033 - Product Image

Drug-Coated Balloon Catheter Market Size, Share & Trends Analysis Report by Type, End Use, Region, and Growth Forecasts, 2026-2033

  • Report
  • 200 Pages
  • Global
From
U.S. Interventional Cardiology And Peripheral Market Size, Share & Trends Analysis Report By Product (Interventional Catheters, Microcatheters, Peripheral Stents), By Application, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Interventional Cardiology And Peripheral Market Size, Share & Trends Analysis Report By Product (Interventional Catheters, Microcatheters, Peripheral Stents), By Application, And Segment Forecasts, 2025 - 2033

  • Report
  • 160 Pages
  • United States
From
Interventional Cardiology Devices Market Size, Share & Trends Analysis Report by Product, Procedures, End Use, Region, and Growth Forecasts, 2026-2033 - Product Image

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report by Product, Procedures, End Use, Region, and Growth Forecasts, 2026-2033

  • Report
  • 100 Pages
  • Global
From
Drug Eluting Balloons - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Drug Eluting Balloons - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Coronary Balloon Catheters Market - Global Forecast 2026-2032 - Product Image

Coronary Balloon Catheters Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.